ArticleCost effectiveness and resource allocation : C/E2013

Cost-effectiveness analysis of treatment with peginterferon-alfa-2a versus peginterferon-alfa-2b for patients with chronic hepatitis C under the public payer perspective in Brazil.

Fabio Mr Barros et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.